3.23.1 html 126 307 1 false 54 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - BALANCE SHEETS Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/StatementBalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 100030 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/StatementBalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss3 STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 100060 - Statement - STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit1 STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 100070 - Statement - STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Statements 6 false false R7.htm 100080 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/StatementStatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 100090 - Disclosure - Organization and Description of Business Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 8 false false R9.htm 100100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1 Summary of Significant Accounting Policies Notes 9 false false R10.htm 100110 - Disclosure - Fair Value Measurements Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFairValueMeasurements1 Fair Value Measurements Notes 10 false false R11.htm 100120 - Disclosure - Funding Arrangements Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFundingArrangements Funding Arrangements Notes 11 false false R12.htm 100130 - Disclosure - Collaboration and License Agreements Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements1 Collaboration and License Agreements Notes 12 false false R13.htm 100140 - Disclosure - Leases Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureLeases Leases Notes 13 false false R14.htm 100150 - Disclosure - Balance Sheet Components Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureBalanceSheetComponents1 Balance Sheet Components Notes 14 false false R15.htm 100160 - Disclosure - Commitment and Contingencies Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureCommitmentAndContingencies Commitment and Contingencies Notes 15 false false R16.htm 100170 - Disclosure - Equity Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquity2 Equity Notes 16 false false R17.htm 100180 - Disclosure - Equity Incentive Plan and Stock-Based Compensation Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensation1 Equity Incentive Plan and Stock-Based Compensation Notes 17 false false R18.htm 100190 - Disclosure - Income Taxes Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 18 false false R19.htm 100200 - Disclosure - Net Loss Per Share Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 100210 - Disclosure - Related Party Transactions Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 20 false false R21.htm 100220 - Disclosure - Defined Contribution Plan Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureDefinedContributionPlan Defined Contribution Plan Notes 21 false false R22.htm 100240 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1 22 false false R23.htm 100250 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFairValueMeasurements1 23 false false R24.htm 100260 - Disclosure - Leases (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureLeases 24 false false R25.htm 100270 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureBalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureBalanceSheetComponents1 25 false false R26.htm 100280 - Disclosure - Equity (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityTables Equity (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquity2 26 false false R27.htm 100290 - Disclosure - Equity Incentive Plan and Stock-Based Compensation (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensationTables Equity Incentive Plan and Stock-Based Compensation (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensation1 27 false false R28.htm 100300 - Disclosure - Income Taxes (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxes 28 false false R29.htm 100310 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureNetLossPerShare 29 false false R30.htm 100320 - Disclosure - Organization and Description of Business - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails Organization and Description of Business - Additional Information (Details) Details 30 false false R31.htm 100330 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 31 false false R32.htm 100340 - Disclosure - Fair Value Measurements - Summary of Financial Assets Fair Value Measurement on Recurring Basis (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsFairValueMeasurementOnRecurringBasisDetails Fair Value Measurements - Summary of Financial Assets Fair Value Measurement on Recurring Basis (Details) Details 32 false false R33.htm 100350 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 33 false false R34.htm 100360 - Disclosure - Funding Arrangements - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureFundingArrangementsAdditionalInformationDetails Funding Arrangements - Additional Information (Details) Details 34 false false R35.htm 100370 - Disclosure - Collaboration and License Agreements - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails Collaboration and License Agreements - Additional Information (Details) Details 35 false false R36.htm 100380 - Disclosure - Leases - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 36 false false R37.htm 100390 - Disclosure - Leases - Summary of Maturities of Lease Liabilities (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetails Leases - Summary of Maturities of Lease Liabilities (Details) Details 37 false false R38.htm 100400 - Disclosure - Leases - Summary of Total Lease Expense (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureLeasesSummaryOfTotalLeaseExpenseDetails Leases - Summary of Total Lease Expense (Details) Details 38 false false R39.htm 100410 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetails Balance Sheet Components - Summary of Accrued Liabilities (Details) Details 39 false false R40.htm 100420 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 40 false false R41.htm 100430 - Disclosure - Equity - Shares of Common Stock Reserved for Future Issuance (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquitySharesOfCommonStockReservedForFutureIssuanceDetails Equity - Shares of Common Stock Reserved for Future Issuance (Details) Details 41 false false R42.htm 100440 - Disclosure - Equity - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityAdditionalInformationDetails Equity - Additional Information (Details) Details 42 false false R43.htm 100450 - Disclosure - Equity - Schedule of Redeemable Convertible Preferred Stock (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityScheduleOfRedeemableConvertiblePreferredStockDetails Equity - Schedule of Redeemable Convertible Preferred Stock (Details) Details 43 false false R44.htm 100460 - Disclosure - Equity Incentive Plan and Stock-Based Compensation - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensationAdditionalInformationDetails Equity Incentive Plan and Stock-Based Compensation - Additional Information (Details) Details 44 false false R45.htm 100470 - Disclosure - Equity Incentive Plan and Stock-Based Compensation - Summary of Weighted Average Assumptions Used to Value Options Granted (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensationSummaryOfWeightedAverageAssumptionsUsedToValueOptionsGrantedDetails Equity Incentive Plan and Stock-Based Compensation - Summary of Weighted Average Assumptions Used to Value Options Granted (Details) Details 45 false false R46.htm 100480 - Disclosure - Equity Incentive Plan and Stock-Based Compensation - Summary of Total Stock-Based Compensation (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensationSummaryOfTotalStockbasedCompensationDetails Equity Incentive Plan and Stock-Based Compensation - Summary of Total Stock-Based Compensation (Details) Details 46 false false R47.htm 100490 - Disclosure - Equity Incentive Plan and Stock-Based Compensation - Summary of Stock Plan Activity (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureEquityIncentivePlanAndStockbasedCompensationSummaryOfStockPlanActivityDetails Equity Incentive Plan and Stock-Based Compensation - Summary of Stock Plan Activity (Details) Details 47 false false R48.htm 100510 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 48 false false R49.htm 100520 - Disclosure - Income Taxes - Provision for Income Taxes Differs from Tax Expense (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDiffersFromTaxExpenseDetails Income Taxes - Provision for Income Taxes Differs from Tax Expense (Details) Details 49 false false R50.htm 100530 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxesComponentsOfDeferredTaxAssetsDetails Income Taxes - Components of Deferred Tax Assets (Details) Details 50 false false R51.htm 100540 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Details) Details 51 false false R52.htm 100550 - Disclosure - Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureNetLossPerShareSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetails Net Loss Per Share - Summary of Computation of Basic and Diluted Net Loss Per Share (Details) Details 52 false false R53.htm 100560 - Disclosure - Net Loss Per Share - Schedule of Potentially Dilutive Securities Not Included in Diluted Per Share Calculation (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesNotIncludedInDilutedPerShareCalculationDetails Net Loss Per Share - Schedule of Potentially Dilutive Securities Not Included in Diluted Per Share Calculation (Details) Details 53 false false R54.htm 100570 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 54 false false R55.htm 100580 - Disclosure - Defined Contribution Plan Additional Information (Details) Sheet http://www.an2therapeutics.com/20221231/taxonomy/role/DisclosureDefinedContributionPlanAdditionalInformationDetails Defined Contribution Plan Additional Information (Details) Details 55 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept GovernmentContractorsRevenueRecognitionPolicyPolicyTextBlock in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. antx-20221231.htm 6158 [dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. antx-20221231.htm 7828 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage - antx-20221231.htm 8 antx-20221231.htm antx-20221231.xsd antx-20221231_cal.xml antx-20221231_def.xml antx-20221231_lab.xml antx-20221231_pre.xml antx-ex10_17.htm antx-ex10_18.htm antx-ex23_1.htm antx-ex31_1.htm antx-ex31_2.htm antx-ex32_1.htm antx-ex32_2.htm antx-ex4_3.htm img90168601_0.jpg img90168601_1.jpg img90168601_2.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true